DAR ES SALAAM — [World Bank] Ethiopia is transforming from an import-dependent market into a pharmaceutical manufacturing hub. After becoming the 9th African nation to reach WHO Maturity Level 3, local production now exceeds 40% of medicine supply. This WBG feature examines how regulation, the Kilinto Special Economic Zone, and research at AHRI and CDT-Africa are driving jobs, exports, and health sovereignty. On a typical day in Addis Ababa, analysts at the Ethiopian Food and Drug Authority (EFDA) work in laboratories testing samples
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.